Sponsor pipeline

CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. clinical trial pipeline

Get alerts when CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
4
Phase 2
3
Phase 3
5
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07465263 A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial… Heterozygous Familial Hypercholesterolemia (HeFH) Recruiting 2026-07-08
NCT07421297 A Study to Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese… Non-familial Hypercholesterolemia and Mixed Hyperlipidemia Recruiting 2026-04-07
NCT07635914 A Study Evaluating Aprocitentan Tablets(SYH9108) for the Treatment of Resistant… Resistant Hypertension Not Yet Recruiting 2026-06-09
NCT07421284 A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With… Non-familial Hypercholesterolemia and Mixed Hyperlipidemia Not Yet Recruiting 2026-02-19
NCT05717764 Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With… Recurrent Metastatic Nasopharyngeal Carcinoma Not Yet Recruiting 2023-02-08
Phase 2
NCT07591298 Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in… Diagnosed With HoFH Recruiting 2026-07-31
NCT07695597 A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia Mixed Hyperlipidemia Recruiting 2026-07-22
NCT07640217 A Phase II Clinical Study of SYH2068 Injection in Adults With Elevated Lipoprotein(a) Adult Participants With Elevated Lipoprotein(a) Not Yet Recruiting 2026-06-10
Phase 1
NCT07241910 A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Healthy Subjects Recruiting 2026-06-08
NCT07241923 A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and… Healthy Subjects (HS) Recruiting 2025-12-01
NCT07096869 Bioequivalence Study of Paclitaxel Protein-bound Particles for Injectable Suspension… Bioequivalence Recruiting 2025-07-31
NCT06842537 Study of SYH2062 Injection in Healthy Chinese Volunteers Healthy Chinese Volunteers Recruiting 2025-04-30
Not applicable
NCT07493551 A Bioequivalence Study of PP3M in Patients With Schizophrenia Schizophrenia Recruiting 2026-03-25
NCT07547384 Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With… Schizophrenia Not Yet Recruiting 2026-04-23

Disease areas by active trials

Schizophrenia (2) · Head & Neck Cancer (1) · Hypertension (1)

Get alerts when CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free